PR Newswire BASEL, Switzerland, March 26, 2025 Results from Phase 2a Trial demonstrate a good safety and tolerability profile of VXM01 and Avelumab Combination Therapy in Glioblastoma, supporting further investigation of VXM01 BASEL, ...
PR Newswire NEW YORK, March 26, 2025 NEW YORK, March 26, 2025 /PRNewswire/ -- Today Mediaplanet announces the launch of Blood Health, designed to raise awareness of blood disorders, cancers, and bleeding disorders. This wide-reaching ...
PR Newswire CAMBRIDGE, Mass., March 26, 2025 Updated data confirms statistically significant 32% higher ORR and 3.5 month longer PFS in second-line CRC patients with high DKK1 levels treated with sirexatamab plus bevacizumab and chemotherapy ...
PR Newswire CHENGDU, China, March 25, 2025 CHENGDU, China, March 25, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company has received a clinical trial notice approving the ...
PR Newswire BOSTON, March 25, 2025 -- Abstract accepted for late-breaking poster presentation – -- EO-1022 is a potentially differentiated HER3 ADC being developed for the treatment of solid tumors, including breast and non-small cell ...
PR Newswire TORONTO, March 25, 2025 FACIT gets 'elbows up' on building local health innovation companies that strengthen Ontario's prosperity TORONTO, March 25, 2025 /PRNewswire/ - The winning pitch at FACIT's sold-out annual Falcons' ...
PR Newswire SAN JOSE, Calif., March 25, 2025 VERDI's personalized vaccines have demonstrated safety and efficacy in cancer patients SAN JOSE, Calif., March 25, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") ...
PR Newswire LAS VEGAS, March 24, 2025 As a BCMA-targeting CAR T-cell therapy, CARVYKTI addresses a high unmet need in relapsed or refractory multiple myeloma patients. With promising clinical efficacy, durable responses, and growing adoption ...
PR Newswire SUZHOU, China, March 23, 2025 SUZHOU, China, March 23, 2025 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a biopharmaceutical company dedicated to developing innovative cancer therapies, today announced the ...
PR Newswire SAN FRANCISCO and SUZHOU, China, March 23, 2025 SAN FRANCISCO and SUZHOU, China, March 23, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, ...
Tobacco control prevented nearly 4 million premature lung cancer deaths in the U.S., adding over 76 million years of life between 1970 and 2022.
Residual cancer can remain undetected despite clear scans, potentially leading to worse outcomes and higher risks of recurrence.
CAR-T pipeline advances, with blood cancers at the forefront of development, driving new treatment innovations.
Colorectal cancer is linked to a higher risk of cardiovascular mortality, highlighting the need for heart health monitoring in patients with the disease.
Discover the newly developed cobalt-doped iron oxide nanoparticles, improving magnetic hyperthermia treatment for ovarian cancer.
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2025
Careers